Comments
Loading...
IR-Med Analyst Ratings and Price Targets | OTC:IRME | Benzinga
IR-Med Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for IR-Med Corp from these most-recent analyst ratings.
Analyst Ratings for IR-Med
Data brought to you by Benzinga APIs
FAQ
What is the target price for IR-Med (IRME) stock?
There is no price target for IR-Med
What is the most recent analyst rating for IR-Med (IRME)?
There is no analyst for IR-Med
When was the last upgrade for IR-Med (IRME)?
There is no last upgrade for IR-Med
When was the last downgrade for IR-Med (IRME)?
There is no last downgrade for IR-Med.
When is the next analyst rating going to be posted or updated for IR-Med (IRME)?
There is no next analyst rating for IR-Med.
Is the Analyst Rating IR-Med (IRME) correct?
There is no next analyst rating for IR-Med.
Browse analyst ratings and price targets on all stocks.